[go: up one dir, main page]

EP1427425A4 - METHOD FOR THE TREATMENT OF OBESITAS AND MUSCULATOR FLUSHING AND ERGONIC TOOLS - Google Patents

METHOD FOR THE TREATMENT OF OBESITAS AND MUSCULATOR FLUSHING AND ERGONIC TOOLS

Info

Publication number
EP1427425A4
EP1427425A4 EP01948319A EP01948319A EP1427425A4 EP 1427425 A4 EP1427425 A4 EP 1427425A4 EP 01948319 A EP01948319 A EP 01948319A EP 01948319 A EP01948319 A EP 01948319A EP 1427425 A4 EP1427425 A4 EP 1427425A4
Authority
EP
European Patent Office
Prior art keywords
musculator
ergonic
obesitas
flushing
tools
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01948319A
Other languages
German (de)
French (fr)
Other versions
EP1427425A1 (en
Inventor
William Winder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham Young University
Original Assignee
Brigham Young University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Young University filed Critical Brigham Young University
Publication of EP1427425A1 publication Critical patent/EP1427425A1/en
Publication of EP1427425A4 publication Critical patent/EP1427425A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP01948319A 2000-06-09 2001-06-11 METHOD FOR THE TREATMENT OF OBESITAS AND MUSCULATOR FLUSHING AND ERGONIC TOOLS Withdrawn EP1427425A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21070800P 2000-06-09 2000-06-09
US210708P 2000-06-09
PCT/US2001/018812 WO2001093874A1 (en) 2000-06-09 2001-06-11 Method of treatment of obesity and paralyzed muscle and ergogenic aids

Publications (2)

Publication Number Publication Date
EP1427425A1 EP1427425A1 (en) 2004-06-16
EP1427425A4 true EP1427425A4 (en) 2006-04-05

Family

ID=22783952

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01948319A Withdrawn EP1427425A4 (en) 2000-06-09 2001-06-11 METHOD FOR THE TREATMENT OF OBESITAS AND MUSCULATOR FLUSHING AND ERGONIC TOOLS

Country Status (3)

Country Link
EP (1) EP1427425A4 (en)
AU (1) AU2001269785A1 (en)
WO (1) WO2001093874A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192495B1 (en) 2002-03-21 2005-02-16 Universidad De Barcelona NEW THERAPEUTIC USE OF RIBOSIDE 5-AMINOIMIDAZOL-4-CARBOXAMIDE (ACADESIN).
DK1633883T3 (en) * 2003-06-17 2009-01-26 Medical Res Council Method for analyzing LKB1 phosphorylation activity
US20070213295A1 (en) * 2006-01-16 2007-09-13 The Board Of Regents Of The University Of Texas System Methods and compositions for inducing torpor in a subject
AU2007341981A1 (en) 2006-12-29 2008-07-10 The Salk Institute For Biological Studies Methods for enhancing exercise performance
EP2234622A4 (en) * 2007-12-28 2011-03-09 Salk Inst For Biological Studi METHOD FOR INCREASING MUSCLE PERFORMANCE AND MUSCLE TONUS
WO2012114204A2 (en) * 2011-02-15 2012-08-30 Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto Methods of treating mitochondrial dysfunction
US8895520B2 (en) 2011-10-26 2014-11-25 Universite Nice Sophia Antipolis Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide
WO2020050935A2 (en) 2018-08-06 2020-03-12 Skylark Bioscience Llc Amp-activated protein kinase activating compounds and uses thereof
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5777100A (en) * 1990-08-10 1998-07-07 Gensia Inc. AICA riboside analogs
WO2001093873A1 (en) * 2000-06-06 2001-12-13 Trustees Of Boston University Use of aicar and related compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658889A (en) * 1989-01-24 1997-08-19 Gensia Pharmaceuticals, Inc. Method and compounds for aica riboside delivery and for lowering blood glucose
WO2001010449A1 (en) * 1999-08-09 2001-02-15 Trustees Of Boston University Method of maintaining vascular integrity using aicar (5-amino-4-imidazole riboside) and related compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5777100A (en) * 1990-08-10 1998-07-07 Gensia Inc. AICA riboside analogs
WO2001093873A1 (en) * 2000-06-06 2001-12-13 Trustees Of Boston University Use of aicar and related compounds

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HOLMES, B.F. ET AL.: "Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle", AM J PHYSIOL, vol. 87, no. 5, November 1999 (1999-11-01), pages 1990 - 1995, XP002364671 *
See also references of WO0193874A1 *
VINCENT M FJ ET AL: "HYPOGLYCAEMIC EFFECT OF AICARIBOSIDE IN MICE", DIABETOLOGIA, BERLIN, DE, vol. 39, no. 10, 1996, pages 1148 - 1155, XP008008094, ISSN: 0012-186X *
WINDER,W.W AND HARDIE, D.G.: "AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes", AM J PHYSIOL ENDOCRINOL METAB, vol. 277, no. 1, July 1999 (1999-07-01), pages E1 - E10, XP002364672 *
WINDER,W.W. ET AL.: "Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle", J APPL PHYSIOL, vol. 88, 2000, pages 2219 - 2226, XP002364670 *

Also Published As

Publication number Publication date
EP1427425A1 (en) 2004-06-16
AU2001269785A1 (en) 2001-12-17
WO2001093874A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
DE60227095D1 (en) COMPOSITIONS AND METHODS FOR TREATING SEPARATED GIPS
DE60122532D1 (en) METHOD FOR TREATING SEVERAL BORROOCH INTERVALS
DE60132767D1 (en) METHOD AND DEVICE FOR PRODUCING OVERLAP CLEANING
DE60231601D1 (en) DEVICE AND METHOD FOR TREATMENT
EP1701664A4 (en) SYSTEM AND METHOD FOR THE TREATMENT OF TISSUE
DE50006193D1 (en) METHOD FOR PRODUCING OTOPLASTICS AND OTOPLASTICS
DE69810584D1 (en) Waste treatment method and method
EP1324780A4 (en) METHODS OF TREATING HERZARRHYTHMIA
DE60120520D1 (en) METHOD FOR TREATING WASTEWATER
EP1482962A4 (en) METHOD FOR THE TREATMENT OF TRX-MEDIATED ILLNESSES
ATE259245T1 (en) METHOD FOR TREATING MOTION DISORDERS
DE60143831D1 (en) TAILORED ROHTEIL AND METHOD FOR THE PRODUCTION OF THE PART
DE60122839D1 (en) Process for the treatment of chromate polluted wastewater
DE60136477D1 (en) RETINOIDES FOR THE TREATMENT OF EMPHYSEM
EP1443820A4 (en) COMPOSITION AND METHOD FOR TREATING THE TRANSPLANT HOST REACTION
DE60128788D1 (en) COMPOSITION AND METHOD FOR COMBATING PLANT-DAMAGED ARTHROPODES
DE60114439D1 (en) METHOD FOR THE ANTIMICROBIAL TREATMENT OF FIBER MATERIALS
EP1635801A4 (en) METHOD FOR TREATING AND PREVENTING CARDIAC ARTHYTHMIA
DE60223688D1 (en) METHOD FOR THE TREATMENT OF MULTIPLE MYELOMA
DE60014876D1 (en) COMPOUNDS AND METHODS FOR TREATING ASTHMA, ALLERGY AND INFLAMMATORY DISEASES
DE60035326D1 (en) Process for the treatment of wastewater
DE60136748D1 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
DE60036899D1 (en) CHEMICAL AND METHOD FOR WATER TREATMENT
DE69834578D1 (en) METHOD FOR THE TREATMENT OF CEMENT TEMPERATURES
DE60133996D1 (en) Cosmetic METHOD FOR TREATING CELLULITE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17P Request for examination filed

Effective date: 20030314

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/00 20060101ALI20060131BHEP

Ipc: A61P 21/00 20060101ALI20060131BHEP

Ipc: A61K 31/70 20060101AFI20011219BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20060220

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060921